Ozempic

What is Ozempic?

Ozempic is Novo Nordisk's brand semaglutide, FDA-approved for type 2 diabetes in adults, as a weekly injection pen. It is the same medication as Wegovy: one molecule, two brand names, each carrying its own FDA-approved use. Weight management is Wegovy's indication, and which version fits a given prescription is a matter for the label and a licensed prescriber.

Who offers brand access right now

These plans cover brand semaglutide access as providers publish it, Wegovy or Ozempic, with the all-in monthly total including required fees. Brand access comes in two shapes, and the range reflects both: at the low end are plans priced as a visit membership, with the medication billed separately through insurance or the pharmacy, while plans that include the medication in the price sit higher. The comparison list shows every plan with its price and state availability.

Brand cost by dose

Brand plans are priced by dose like the label's own tiers. Each provider counts once per dose here, at its lowest all-in monthly price for that dose.

Ozempic and insurance

Because Ozempic's approved use is type 2 diabetes, insurance coverage runs through that indication, and a plan that covers Ozempic for diabetes may not cover semaglutide for weight management. Some telehealth plans here are built around that coverage: the plan price is the visit membership and the medication bills through your insurance. Others include the medication as a cash price, and each plan's card shows which fees its total carries.

Ozempic and compounded semaglutide

Compounded plans are a pricing alternative to the brand versions, intended to contain the same active ingredient, though compounded versions are not FDA-approved or verified as equivalent. Both paths appear side by side in the directory.

This page is a general reference, not medical advice. Whether Ozempic fits your situation, and the dose, is a decision for you and a licensed prescriber, guided by the FDA label.